Photodynamic therapy by laserphyrin and semi-conductor laser in multidisciplinary treatment for unresectable bile duct carcinoma;safety and efficacy

Phase 1

• Conditions: nresectable bile duct carcinoma

• Registration Number: JPRN-UMIN000025828
• Lead Sponsor: niversity of Miyazaki Faculty of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-02-01
• Study Completion: 2019-03-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients requiring radiation therapy as a local treatment (2)Patients who cannot receive laser irradiation to the tumor by any reasons (3)Patients with serious co-morbidity(malignant hypertension, severe congestive cardiac failure, severe hepatic failure, cardiac infarction withtin 3 months, terminal stage of cirrhosis, uncontrolled diabetes,severe pulmonary fibrosis, active interstitial peumonitis etc) (4)Patients with uncontrolled infectious diseases including actibe tuberclosis (5)atients who are difficult to limitatehospital stay under dark room (6)Porphyria patients (7)Patients diagnosed as severe mental disorders or dementia (8)Patients who attend other clinical study (9)Patients who are hypersensitive for laserphyrin (10)Female patients with pregnancy, pregnant-suspicious and breast-feeding (11)Unresctable bile duct patients in whom the better prognosis are not expected by the researcher's judgement. (12)Other patients who are not stable for clinical study by the judgement of attendant doctors

Study & Design

• Study Type: Interventional
• Study Design: Not specified